A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/1997
12/04/1997	WO1997045111A1 Phenyl derivatives useful as blockers of chloride channels
12/04/1997	WO1997045105A1 Compositions and methods for treating or preventing diseases of body passageways
12/04/1997	DE19622222A1 Use of sodium=proton exchange inhibitor
12/04/1997	CA2619901A1 Pharmaceutical for treatment of neurological and neuropsychiatric disorders
12/04/1997	CA2252718A1 Compositions for use in embolizing blood vessels
12/04/1997	CA2227811A1 Cytokine production inhibitors, formulations thereof and their use in medicine, and methods for their identification
12/03/1997	EP0810220A1 Arylacrylamide derivatives as 5HT1 agonists or antagonists
12/03/1997	EP0810207A1 Bis-ortho-substituted benzoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicaments containing them
12/03/1997	EP0810206A1 Substituted 2-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicament containing them
12/03/1997	EP0810205A1 Substituted 1-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicaments containing them
12/03/1997	EP0809701A1 Calcineurin regulatable adenylate cyclase
12/03/1997	EP0809655A1 PEPTIDES AND PEPTIDOMIMETICS WITH STRUCTURAL SIMILARITY TO HUMAN p53 THAT ACTIVATE p53 FUNCTION
12/03/1997	EP0809642A1 Imidazo 1,2-a]pyridines for the treatment of cns and cardiac diseases
12/03/1997	EP0809636A1 Substituted isoxazoles for the treatment of inflammation
12/03/1997	EP0809635A1 Alpha-substituted hydrazides having calpain inhibitory activity
12/03/1997	EP0809517A1 Anti-transforming growth factor-beta gene therapy
12/03/1997	EP0809515A1 Therapeutic inhibitor of vascular smooth muscle cells
12/03/1997	EP0809511A1 Inhibition of angiogenesis using interleukin-12
12/03/1997	EP0809499A1 Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
12/03/1997	EP0730651A4 Surface loop structural analogues of fibroblast growth factors
12/03/1997	EP0717733B1 Fused tricyclic heteroaromatic derivatives as dopamine receptor subtype ligands
12/03/1997	CN1166825A Metalloproteinase inhibitors
12/03/1997	CN1166490A Prep of novel mercaptoacetylamide derivatives
12/03/1997	CN1036591C Carbamates of repamycin
12/03/1997	CN1036590C Process for preparation of mercaptoacetylamide derivatives
12/03/1997	CN1036588C Oxazolidine derivatives having anti-diabetic and anti-obesity properties, their preparation and their therapeutic uses
12/02/1997	US5693676 Using nitroglycerin to treat anal fissures or ulcers, hemorrhoids, levator spasms
12/02/1997	US5693672 3,4,5-substituted benzoylguanidines, process for their preparation, their use as a medicament or diagnostic and medicament containing them
12/02/1997	US5693665 Alkylated (hetero) cyclic compounds
12/02/1997	US5693657 Useful for treating hypercholesterolemia or atherosclerosis
12/02/1997	US5693655 Substituted di-indolylpiperidines for treatment of nervous system disorders
12/02/1997	US5693653 Administering an antidepressants
12/02/1997	US5693652 Benzimidazoles for ischemic heart conditions
12/02/1997	US5693650 4-(Quinolin-2-yl-methoxy)-phenyl-acetic acid derivatives
12/02/1997	US5693637 Bicycle derivatives, their preparation and use
12/02/1997	US5693636 Bicyclic fibrinogen antagonists
12/02/1997	US5693633 Angiotensin II antagonists
12/02/1997	US5693619 Method of using renin inhibiting N-(2-amino-2-oxoethyl) butanediamide derivatives
12/02/1997	US5693614 Drug for the treatment of senile dementia of the ischemic and hypoglycemic types
12/02/1997	US5693612 Used for prophylaxis and treatment of disorders of the circulation, bones and in tumor therapy, and as antimicrobial and antiviral active compounds
11/1997
11/30/1997	CA2206466A1 Carbamoyl substituted heterocycles
11/28/1997	CA2206198A1 Bis-ortho-substituted benzoylguanidines, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
11/27/1997	WO1997044360A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044359A1 Novel human g-protein coupled receptor
11/27/1997	WO1997044350A1 Inhibitors of protein farnesyl transferase
11/27/1997	WO1997044329A1 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists
11/27/1997	WO1997044326A1 Aryl pyrimidine derivatives
11/27/1997	WO1997044315A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
11/27/1997	WO1997044054A2 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997	WO1997044035A1 Methods of treating hypertension
11/27/1997	WO1997044029A1 Methods of increasing nitric oxide synthesis
11/27/1997	WO1997038665A3 Inhibitors of farnesyl-protein transferase
11/27/1997	CA2256568A1 Type-2 chemokine binding proteins and methods of use therefor
11/27/1997	CA2255910A1 Methods of treating hypertension
11/27/1997	CA2255792A1 Methods of increasing nitric oxide synthesis
11/27/1997	CA2255705A1 Aryl pyrimidine derivatives
11/27/1997	CA2253934A1 Inhibitors of protein farnesyl transferase
11/27/1997	CA2253342A1 Biphenylsulfonamide matrix metalloproteinase inhibitors
11/26/1997	EP0808899A2 Human marco scavenger receptor (HMarcoSR)
11/26/1997	EP0808327A1 Proline derivatives useful as inhibitors of human leukocyte elastase
11/26/1997	EP0808324A1 Compositions and methods for the treatment and diagnosis of cardiovascular disease
11/26/1997	EP0808316A1 Vasoconstrictive substituted 2,3-dihydro-1,4-dioxinopyridines
11/26/1997	EP0808172A2 Combination of angiotensin converting enzyme inhibitor and side-effect-reduced amount of aldosterone antagonist
11/26/1997	EP0808171A2 Combination of angiotensin converting enzyme inhibitor, side-effect-reduced amount of aldosterone antagonist and diuretic
11/26/1997	EP0808162A2 Use of carbazole compounds for the treatment of congestive heart failure
11/26/1997	EP0700398B1 Psoralen derivatives, their preparation and use as medicaments
11/26/1997	EP0548095B1 Pharmaceutical compositions containing superoxide dismutase from bacillus stearothermophilus and bacillus caldotenax
11/26/1997	CN1166173A Tetrahydropyridine-(or 4-hydroxypiperidine) Alkylazoles having an affinity for sigma and/or 5HTIA receptors
11/26/1997	CN1165817A New inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them
11/26/1997	CN1165694A Effective medicine for treating apoplexy
11/26/1997	CN1165693A Danma erdong pills for strengthening heart
11/26/1997	CN1165655A Method of treating conditions with estrogen agonists
11/25/1997	US5691382 Enzyme inhibitors for cardiovascular disorders
11/25/1997	US5691381 Antagonist of tumor necrosis factor, antiinflammatory agent, antiarthritic agent
11/25/1997	US5691375 Method for preventing or reducing risk of onset of cardiovascular events employing an HMG CoA reductase inhibitor
11/25/1997	US5691373 Nonpeptide endothelin antagonists I
11/25/1997	US5691369 Cardiovascular disorders
11/25/1997	US5691368 Therapy for neurodegenerative disorders
11/25/1997	US5691366 Unsaturated nitro oxime formed by reaction of dinitrogen trioxide with diolefin ether, sulfide or amine to be used as vasodilators
11/25/1997	US5691361 1,4-dihydropyridine derivatives, a process for their preparation and their use for influencing the blood flow
11/25/1997	US5691354 Treating cardiovascular disorders
11/25/1997	US5691353 Method of inhibiting aortal smooth muscle cell proliferation using naphthyl compounds
11/25/1997	US5691348 Pyridyl imidazole derivatives and processes for the preparation thereof
11/25/1997	US5691347 Angiotensin ii inhibitors and vasoconstriction
11/25/1997	US5691344 Vasoconstrictive substituted dihydropyranopyridines
11/25/1997	US5691337 Oxy-phenyl-(phenyl)glycinolamides with heterocyclic substituents
11/25/1997	US5691332 Antiarrhymia agents and cardiovascular disorders
11/25/1997	US5691331 N-(2,4-Dioxo-2,3,4,5-tetrahydro-1H-1,5-benzodiazepin-3yl) -3- amides
11/20/1997	WO1997043304A1 Novel compounds
11/20/1997	WO1997043303A1 Novel compounds
11/20/1997	WO1997043300A1 Adenosine derivatives
11/20/1997	WO1997043287A1 Carboline derivatives
11/20/1997	WO1997043278A1 Somatostatin agonists and antagonists
11/20/1997	WO1997043276A1 Novel 2,3 disubstituted-4(3h)-quinazolinones
11/20/1997	WO1997043260A1 Indole derivatives useful as endothelin receptor antagonists
11/20/1997	WO1997043259A1 Arylalkylpiperazine compounds as antioxidants
11/20/1997	WO1997043247A1 Inhibition of matrix metalloproteases by substituted phenethyl compounds
11/20/1997	WO1997043245A1 Inhibition of matrix metalloproteases by acetylene containing compounds
11/20/1997	WO1997043240A1 INHIBITION OF MATRIX METALLOPROTEASES BY 2-(φ-AROYLALKYL)-4-BIARYL-OXOBUTYRIC ACIDS
11/20/1997	WO1997043239A1 Inhibition of matrix metalloproteases by 2-substituted-4-(4-substitutedphenyl)-4-oxobutyric acids

1 ... 1369 1370 1371 1372 1373 1374 1375 1376 1377 1378 1379 1380 1381 1382 1383 1384 1385 1386 1387 1388 1389 ... 1595